Autoimmune Diseases / 2017 / Article / Tab 5

Research Article

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis

Table 5

Temporal relationship of detectable autoantibodies. Patients without a clear antecedent antibody above the designated threshold were not included in analysis. OR, odds ratio; CI, confidence interval.

Comparison thresholdsAntecedent MPO-ANCA
(%)
Antecedent dsDNAab
(%)
ORCI value
(Fisher’s exact)

MPO-ANCA ≥ 3U/ml
versus
dsDNAab ≥ 3 IU/ml
89 (8/9)11 (1/9)643.4–12110.003

MPO-ANCA ≥ 3 U/ml versus
dsDNAab ≥ 5 IU/ml
100 (10/10)0 (0/10)5.5–<0.001

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.